Solid ESG footprint
Our company is built upon a sustainable foundation substantiating everything we do. The Arctic Bioscience team has developed technology that allows us to utilize the unique chemical composition of herring roe. This raw material was previously considered waste from herring fillet production. With our proprietary extraction methods, herring roe is now utilized to create high-quality extracts for both nutraceutical products and pharmaceutical development. This leaves a robust ESG footprint we are proud of.
Arctic Bioscience develops products based on herring roe. Our portfolio consists of complex lipid extracts and proteins for pharmaceutical and nutraceutical applications.
The ongoing development of a treatment for mild-to-moderate psoriasis (HRO350) has the potential to improve the quality of life for this patient group. Mild-to-moderate psoriasis patients have limited treatment options today, many of which having considerable side-effects.
Arctic Bioscience manufactures high quality products by utilizing a side stream from the herring fishery, which is repurposed for the production of our product portfolio.
The raw material, herring roe, is sustainably sourced from local fisheries.
In 2023 a new company production facility is opening in Ørsta. This facility will make the value chain fully sustainable with local production.
Arctic Bioscience is dedicated to gender balance in its employees and management. Several women hold leadership positions including Medical Director, CFO, and VP of sales and marketing. In the overall organization, 45% of the employees are female.
Arctic Bioscience works towards keeping the company’s carbon footprint at a minimum.
The production plant will be built on a pier by the fjord in Ørsta where the roe can be delivered directly from the fisheries fleet on the Møre coast, yielding a production with a low carbon footprint.
Arctic Bioscience contributes to sustainable value creation with efficient utilization of resources.
Arctic Bioscience is building a new production facility in Ørsta, which will contribute to local industry and infrastructure. We have a dedicated R&D department working on developing novel products, and a medical department dedicated to the clinical aspects of our drug development projects.
Arctic Bioscience contributes to conserving and using marine resources in a way that promotes sustainable development. We ensure that all raw materials are harvested in a sustainable way following strict quota regulations.
Solid ESG footprint
Our company is built upon a sustainable foundation substantiating everything we do. The Arctic Bioscience team has developed technology that allows us to utilize the unique chemical composition of herring roe. This raw material was previously considered waste from herring fillet production. With our proprietary extraction methods, herring roe is now utilized to create high-quality extracts for both nutraceutical products and pharmaceutical development. This leaves a robust ESG footprint we are proud of.
Arctic Bioscience creates scientifically documented health-promoting products based on herring roe. Our portfolio consists of high DHA marine omega-3 phospholipid extracts and proteins for pharmaceutical and nutraceutical applications.
The ongoing development of a treatment for mild-to-moderate psoriasis (HRO350) would improve the quality of life for this patient group significantly. Psoriasis patients have limited treatment options today, many of which having considerable side-effects. HRO350 could be the first oral treatment for psoriasis globally without reported side effects.
Arctic Bioscience is dedicated to gender balance in its employees and management. Several women hold leadership positions including Medical Director, CFO, and VP of sales and marketing. In the overall organization, 45% of the employees are female.
Arctic Bioscience contributes to sustainable value creation with efficient utilization of resources in an environmentally conscious way.
Arctic Bioscience is building a new factory in Ørsta for pharmaceutical and nutraceutical production, which will contribute to local industry and infrastructure. We have a dedicated R&D department working on developing novel products, and a medical department dedicated to running clinical trials.
Arctic Bioscience is creating premium products by utilizing a residual raw material. The by-product is repurposed for the production of our products.
The raw material is sourced from local fisheries.
In 2023 a new company production facility will be ready in Ørsta. This will make the value chain fully sustainable with local production.
Arctic Bioscience work towards keeping the company’s carbon footprint at a minimum. The production factory will be built on a pier by the fjord in Ørsta where the roe can be delivered directly from the fisheries fleet on the Møre coast, yielding a production with a low carbon footprint.
Arctic Bioscience contributes to conserving and using marine resources in a way that promotes sustainable development. We ensure that all resources used are harvested in a sustainable way following the quota regulations.
Utilizing a residual raw material
In the filleting of herring today, the roe is considered a residual raw material that should be utilized. It is only modest amounts of roe that are used for human consumption today. Herring roe is a unique resource and the nutrients are of great nutritional value. We are proud to be utilizing this fantastic raw material being the main component of our products.
Utilizing a residual raw material
In the filleting of herring today, the roe is considered a residual raw material that should be utilized. It is only modest amounts of roe that are used for human consumption today. Herring roe is a unique resource and the nutrients are of great nutritional value. We are proud to be utilizing this fantastic raw material being the main component of our products.
Norwegian Spring-Spawning Herring
Norwegian spring-spawning herring has been a cornerstone of the Norwegian and European diet for several thousand years. Overfishing led to quota-controlled catches from the mid-1960s. By 1970, virtually the entire spawning population had disappeared. The collapse was due to a combination of overfishing and natural population fluctuations. Improved knowledge, enhanced fisheries management and enforcement of stricter regulations have made it possible for the herring population to return. Today the population of herring is strictly monitored to ensure a healthy and sustainable population. The Norwegian Spring Spawning-Herring fisheries are certified by MSC (Marine Stewardship Council), an international non-profit organization established to ensure sustainable fishing.
Norwegian Spring-Spawning Herring
Norwegian spring-spawning herring has been a cornerstone of the Norwegian and European diet for several thousand years. Overfishing led to quota-controlled catches from the mid-1960s. By 1970, virtually the entire spawning population had disappeared. The collapse was due to a combination of overfishing and natural population fluctuations. Improved knowledge, enhanced fisheries management and enforcement of stricter regulations have made it possible for the herring population to return. Today the population of herring is strictly monitored to ensure a healthy and sustainable population. The Norwegian Spring Spawning-Herring fisheries are certified by MSC (Marine Stewardship Council), an international non-profit organization established to ensure sustainable fishing.
